Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.2900
-0.0150 (-4.92%)
Mar 31, 2025, 1:40 PM EDT - Market open

Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $11.32 million. The enterprise value is -$38.15 million.

Market Cap 11.32M
Enterprise Value -38.15M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.21% in one year.

Current Share Class 39.04M
Shares Outstanding 39.04M
Shares Change (YoY) +1.21%
Shares Change (QoQ) +0.48%
Owned by Insiders (%) 8.46%
Owned by Institutions (%) 21.43%
Float 27.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.27
P/TBV Ratio 0.27
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.

Current Ratio 4.18
Quick Ratio 3.90
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -110.77% and return on invested capital (ROIC) is -68.02%.

Return on Equity (ROE) -110.77%
Return on Assets (ROA) -55.23%
Return on Invested Capital (ROIC) -68.02%
Return on Capital Employed (ROCE) -212.02%
Revenue Per Employee n/a
Profits Per Employee -$3.73M
Employee Count 26
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.09% in the last 52 weeks. The beta is 3.01, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y) 3.01
52-Week Price Change -88.09%
50-Day Moving Average 0.42
200-Day Moving Average 1.22
Relative Strength Index (RSI) 33.26
Average Volume (20 Days) 212,407

Short Selling Information

The latest short interest is 1.04 million, so 2.67% of the outstanding shares have been sold short.

Short Interest 1.04M
Short Previous Month 886,263
Short % of Shares Out 2.67%
Short % of Float 3.78%
Short Ratio (days to cover) 4.26

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -96.78M
Pretax Income -113.45M
Net Income -96.94M
EBITDA -95.81M
EBIT -96.78M
Earnings Per Share (EPS) -$2.52
Full Income Statement

Balance Sheet

The company has $51.28 million in cash and $1.22 million in debt, giving a net cash position of $50.06 million or $1.28 per share.

Cash & Cash Equivalents 51.28M
Total Debt 1.22M
Net Cash 50.06M
Net Cash Per Share $1.28
Equity (Book Value) 44.84M
Book Value Per Share 1.15
Working Capital 41.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.17 million and capital expenditures -$33,000, giving a free cash flow of -$97.20 million.

Operating Cash Flow -97.17M
Capital Expenditures -33,000
Free Cash Flow -97.20M
FCF Per Share -$2.49
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.21%
Shareholder Yield n/a
Earnings Yield -814.08%
FCF Yield -816.29%

Analyst Forecast

The average price target for Athira Pharma is $11.25, which is 3,779.31% higher than the current price. The consensus rating is "Buy".

Price Target $11.25
Price Target Difference 3,779.31%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a